Pouillart P - Search Results

1

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer.

Scholl SM, Balloul JM, Le Goc G, Bizouarne N, Schatz C, Kieny MP, von Mensdorff-Pouilly S, Vincent-Salomon A, Deneux L, Tartour E, Fridman W, Pouillart P, Acres B. Scholl SM, et al. Among authors: pouillart p. J Immunother. 2000 Sep-Oct;23(5):570-80. doi: 10.1097/00002371-200009000-00007. J Immunother. 2000. PMID: 11001550 Clinical Trial.

2

[Vaccination against the tumoral mammary epithelial cells expressing MUC1 mucin].

Scholl SM, Pouillart P. Scholl SM, et al. Among authors: pouillart p. Bull Cancer. 1997 Jan;84(1):61-4. Bull Cancer. 1997. PMID: 9180861 French.

3

Tumor antigens and antigen-presenting capacity in breast cancer.

McDermott RS, Beuvon F, Pauly M, Pallud C, Vincent-Salomon A, Mosseri V, Pouillart P, Scholl SM. McDermott RS, et al. Among authors: pouillart p. Pathobiology. 2002-2003;70(6):324-32. doi: 10.1159/000071272. Pathobiology. 2002. PMID: 12865628

4

[Role of cell therapy in the management of cancer].

Fridman WH, Mathiot C, Tartour E, Dorval T, Thiounn N, Pouillart P, Debre B. Fridman WH, et al. Among authors: pouillart p. Bull Cancer. 1995 Mar;82(3):235-6. Bull Cancer. 1995. PMID: 7655161 French. No abstract available.

5

[Immune reactivity and anergy in breast cancer].

Scholl S, Dorval T, Pouillart P. Scholl S, et al. Among authors: pouillart p. Bull Cancer. 1996 Jul;83(7):535-41. Bull Cancer. 1996. PMID: 8868940 French. No abstract available.

6

Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.

Scholl SM, Lidereau R, de la Rochefordière A, Le-Nir CC, Mosseri V, Noguès C, Pouillart P, Stanley FR. Scholl SM, et al. Among authors: pouillart p. Breast Cancer Res Treat. 1996;39(3):275-83. doi: 10.1007/BF01806155. Breast Cancer Res Treat. 1996. PMID: 8877007

7

Is primary chemotherapy useful for all patients with primary invasive breast cancer?

Scholl SM, Beuzeboc P, Harris AL, Pierga JY, Asselain B, Palangié T, Dorval T, Jouve M, Diéras V, Pouillart P. Scholl SM, et al. Among authors: pouillart p. Recent Results Cancer Res. 1998;152:217-26. doi: 10.1007/978-3-642-45769-2_21. Recent Results Cancer Res. 1998. PMID: 9928560 Review.

8

Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients.

Haicheur N, Escudier B, Dorval T, Negrier S, De Mulder PH, Dupuy JM, Novick D, Guillot T, Wolf S, Pouillart P, Fridman WH, Tartour E. Haicheur N, et al. Among authors: pouillart p. Clin Exp Immunol. 2000 Jan;119(1):28-37. doi: 10.1046/j.1365-2249.2000.01112.x. Clin Exp Immunol. 2000. PMID: 10606961 Free PMC article.

9

Targeting HER2 in other tumor types.

Scholl S, Beuzeboc P, Pouillart P. Scholl S, et al. Among authors: pouillart p. Ann Oncol. 2001;12 Suppl 1:S81-7. doi: 10.1093/annonc/12.suppl_1.s81. Ann Oncol. 2001. PMID: 11521727 Free article. Review.

10

Contralateral breast cancer: annual incidence and risk parameters.

Broët P, de la Rochefordière A, Scholl SM, Fourquet A, Mosseri V, Durand JC, Pouillart P, Asselain B. Broët P, et al. Among authors: pouillart p. J Clin Oncol. 1995 Jul;13(7):1578-83. doi: 10.1200/JCO.1995.13.7.1578. J Clin Oncol. 1995. PMID: 7602346

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters